
Change Control
Assess product, process, documentation, training, and validation impact before a change runs.
ExploreThe controlled process for proposing, assessing, approving, implementing, and verifying changes to validated GxP processes, systems, equipment, and documents.
Most quality failures begin as well-intentioned changes nobody fully assessed. Change control exists so that 'good idea' gets the impact analysis, approval, training, and post-implementation verification it needs before going live.

Change control is the controlled process for proposing, assessing, approving, implementing, and verifying changes to anything that can affect a regulated outcome: GxP processes, equipment, facilities, materials, suppliers, methods, computerised systems, and the documents that govern them.
It's a permanent change to how something is done. Not a one-time deviation from how it's normally done (that's a planned deviation). Not a fix for something already broken (that's a CAPA). A new way of doing the thing, going forward.
Every modern quality framework treats change control as one of the load-bearing elements of the quality system. ICH Q10 lists change management as a system element alongside CAPA, deviations, and management review. ISO 13485 and EU GMP carry similar expectations. The reason they all do this is the same: most quality failures begin as well-intentioned changes nobody fully assessed before going live.
Change control isn't paperwork for its own sake. It's the gate that asks four questions before a change goes live: What could this break? Who needs to know? What needs re-validation, re-training, or supplier notification? How will we know it worked?
If you're an inspector and you want to know how a quality system is really run, you don't ask for the SOP binder. You ask to see the last twelve change requests.
Change records show how the organization handles risk in practice. Were impacts assessed seriously? Was the approval path appropriate to the risk? Did training actually reach the people who do the work? Were related documents revised and routed? Is there evidence the change worked after go-live, or did it disappear into the system without follow-up?
Weak change control rarely shows up alone. It shows up in the next deviation, the next batch failure, the next 483 observation, because the same gap (no impact analysis, no training, no effectiveness check) is what let the trouble in.
Inspector perspective: a change request that says "low risk — no impact" with no analysis behind it tells an inspector one of two things. Either the change really was trivial and the program is good at right-sizing the work, or the change wasn't trivial and the team rushed it. The next ten changes in the log usually settle which.
Change control sits in multiple regulations and standards, sometimes by that name and sometimes folded into broader quality system requirements. The references most often cited in findings:
A change moves through a recognizable shape, whether the system is paper or electronic:
The programs that hold up at inspection share a few habits:
If you see the same planned deviation reissued repeatedly, you're looking at a change that should have gone through change control. Inspectors look for this. It's a fast way to identify a change control program that's being routed around.
A change request that holds up at inspection has impact analysis you can read, approvals from the right people in the right order, training to the staff who do the affected work, and an honest answer to "did this actually work?" Complere is built to run that shape of change control end-to-end, in one record, with the evidence captured as the change progresses rather than reconstructed afterwards.
When someone on your team raises a change, the request carries the proposal, the impact assessment across quality and validation and registered scope, the classification it earned, the documents it affects, and the training it requires — all in one record your reviewers, approvers, and an auditor can read end-to-end without opening five other systems. Larger changes can be broken into sub-changes with dependencies so the pieces land in the order your team intends, not in whatever order they happen to finish.
Approval routes are configurable to your classification matrix, not hard-coded. Each approval captures the approver's identity, the workflow step, and the moment they signed; status transitions re-authenticate the signer (SSO or password) at the moment of signing. Templated change categories carry their own approval routes and impact-assessment fields so the depth of work matches the classification rather than the habits of whoever raised the request.
Training-on-change is generated from the request itself, not added as a side activity. Assignments flow to the affected staff with completion tracked back to the change. Effectiveness review is a separate, controlled step — closure can't happen until the review is recorded and signed off, so high-risk changes don't quietly close out without anyone confirming they worked. Cycle time, overdue items, and effectiveness pass rate roll up to dashboards your quality lead and your management review meeting can use.
Every action on the change request and its sub-changes is captured with who did it, when, and what they changed. The history can't be quietly edited or deleted. Your data stays in your own dedicated space and never mixes with another customer's.
For changes that affect the Complere platform itself, your team starts from the Vendor Validation Package rather than re-validating from scratch — the impact of a platform update scopes against the pre-built URS, IQ/OQ/PQ evidence, and traceability matrix you already hold.
What stays with your team is the program around the platform: deciding your classification thresholds, training your staff on what a real impact assessment looks like, and verifying at periodic review that the changes you've shipped are the changes your records show.
Common questions about Change Control sourced from regulatory references and inspection patterns.
CAPA addresses something that's already broken: a deviation, a complaint, an audit finding. Change control governs an intentional change to a validated process, document, system, or piece of equipment. They overlap when a CAPA's corrective action requires a permanent change — in that case the CAPA links to a change request, and the change goes through full impact assessment and approval rather than being implemented under the CAPA alone.
Yes, but the depth scales to the risk. Bypassing small changes is what creates the gap inspectors find — 'this was too small to document' is the most-cited failure pattern. The fix isn't to skip the process; it's to right-size it. A minor classification should still have an impact assessment, an approval, and an effective date — just proportionate to the risk.
When it affects a registered process, specification, claim, or other condition filed with a regulator. ICH Q12 lays out the framework with the concept of Established Conditions (what's in the filing) versus operational details (what can change internally). The impact assessment is what determines which side of the line a change falls on, and getting that classification wrong is a recurring source of post-approval observations.
A planned deviation is a one-time, time-bound departure from an approved procedure with a defined end. A change control is a permanent change to the procedure going forward. The diagnostic: if the same planned deviation is reissued repeatedly, it's not a deviation — it's a change being routed around the change control system, and inspectors look for exactly this pattern.
The effectiveness review is a post-go-live check, scheduled at the time of approval, that asks whether the change delivered what it was supposed to and produced no unintended effects. For high-risk changes it draws on operating data; for low-risk changes it can be a confirmation that the new procedure is in routine use. A change that closes without an effectiveness review is a change with no evidence it worked.
A recurring set: changes implemented before approval was complete; impact assessments that are tick-box exercises with no analysis; missing training-on-change records for the staff doing the affected work; the old version of an SOP still in use after the effective date; and effectiveness reviews scheduled but never performed. The pattern is the same in EU GMP deficiencies under Annex 15 §3.
Yes. EU GMP Annex 11 §10 and 21 CFR Part 11 §11.10(k) both presume a change management process over computerised systems — configuration, validated reports, integrations, infrastructure. The impact-assessment work is the same as for a physical process; the controls being assessed are technical rather than mechanical.
ICH Q12 introduces two concepts: Established Conditions (the elements of a product or process that are formally registered with the agency) and Post-Approval Change Management Protocols (pre-agreed plans for how certain changes will be assessed and reported). Together they let firms manage product lifecycle changes more predictably and reduce the share of changes that require a formal regulatory submission.
Explore related topics, modules, and compliance resources for a deeper understanding of your quality system.

Assess product, process, documentation, training, and validation impact before a change runs.
Explore
The cycle-time data says the wasted days sit at the seams between modules, not with QA.
Explore
What Corrective and Preventive Action means in practice, and how it links back to deviations.
Explore
Region is chosen once, at provisioning — what that locks in for latency, service availability and DR.
Explore
The five seams where the deviation→CAPA→change chain breaks, what an investigator traces backwards, and a seven-question linkage test.
Explore
Change management is a Q10 element. Email chains are still a traditional QMS, even inside a nicer login.
Explore
Assignment from the change, against the revision that will be in force — not a reminder typed later so the matrix stays green.
Explore
A change record earns its keep when the reason, CAPA, document revision, training, and effectiveness evidence stay visible.
Explore
A hybrid record is inspection-ready when the change that moved a procedure can be traced to the effective revision, training, and retained copy.
Explore
Design controls (+41) and process validation (+29) moved most on the device side in FY 2025; the change chain the letters ask to see.
Explore
FDA's first cGMP letter to cite AI names two clauses and one accountability boundary — read backward, the clauses are a record schema.
Explore
Sponsor tagging is a metadata field, not segregation — the SQL probe, the eight auditor requests and the records a sponsor audit asks for.
Explore
Category 5 assumed the software was static at release; Appendix D11 and a model that retrains turn the validation binder into an evidence stream.
Explore
Six predictable CMC and quality gaps that turn a strong first IND into a clinical hold — and where each closes cheaply before the pre-IND meeting.
Explore
Five seams where CDMO quality systems break between shared infrastructure and the sponsor-facing record — and the architecture that closes them.
Explore
Fifteen working days, a citation written against Part 820 as amended, and the CAPA records the response now has to attach.
Explore
Scope, sample and sign the assessment against ISO 13485:2016 as incorporated, then close each gap through change control.
Explore
Supplier quality management is one decision made repeatedly. What it has to produce, what spreadsheets and email cost, and what to demand from an eQMS.
ExploreWalk through the modules and workflows that address this area inside a controlled, validation-ready quality system.